1. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.
- Author
-
Zhang CG, Zhu WJ, Liu Y, Yuan ZQ, Yang SD, Chen WL, Li JZ, Zhou XF, Liu C, and Zhang XN
- Subjects
- ATP Binding Cassette Transporter, Subfamily B, Member 1 genetics, ATP Binding Cassette Transporter, Subfamily B, Member 1 metabolism, Animals, Cell Survival drug effects, Drug Liberation, Drug Resistance, Multiple drug effects, Drug Resistance, Multiple genetics, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm genetics, Female, Gene Expression, Hep G2 Cells, Humans, Hydrogen-Ion Concentration, Liver Neoplasms genetics, Liver Neoplasms metabolism, Liver Neoplasms pathology, Mice, Mice, Nude, Micelles, RNA, Small Interfering metabolism, Tumor Burden drug effects, Xenograft Model Antitumor Assays, ATP Binding Cassette Transporter, Subfamily B, Member 1 antagonists & inhibitors, Antibiotics, Antineoplastic pharmacology, Combined Modality Therapy methods, Doxorubicin pharmacology, Drug Delivery Systems methods, Liver Neoplasms therapy, RNA, Small Interfering genetics
- Abstract
Co-delivery of chemotherapeutics and siRNA with different mechanisms in a single system is a promising strategy for effective cancer therapy with synergistic effects. In this study, a triblock copolymer micelle was prepared based on the polymer of N-succinyl chitosan-poly-L-lysine-palmitic acid (NSC-PLL-PA) to co-deliver doxorubicin (Dox) and siRNA-P-glycoprotein (P-gp) (Dox-siRNA-micelle). Dox-siRNA-micelle was unstable in pH 5.3 medium than in pH 7.4 medium, which corresponded with the in vitro rapid release of Dox and siRNA in acidic environments. The antitumor efficacy of Dox-siRNA-micelle in vitro significantly increased, especially in HepG2/ADM cells, which was due to the downregulation of P-gp. Moreover, almost all the Dox-siRNA-micelles accumulated in the tumor region beyond 24 h post-injection, and the co-delivery system significantly inhibited tumor growth with synergistic effects in vivo. This study demonstrated the effectiveness of Dox-siRNA-micelles in tumor-targeting and MDR reversal, and provided a promising strategy to develop a co-delivery system with synergistic effects for combined cancer therapy.
- Published
- 2016
- Full Text
- View/download PDF